top of page

Oral COVID-19 Treatment Study
For adults with active COVID infections
We are now enrolling for a clinical trial evaluating the effectiveness of an oral investigational medication for the treatment of COVID-19.
Eastside Research Associates has partnered with a sponsor who is researching the effectiveness of an investigational oral treatment for COVID-19 in reducing long-COVID and rebound COVID infections. Healthy adults who have tested positive within the last 5 days may qualify.
If you are interested in participating in this study or have questions about your eligibility, perform a self-check below and request a phone screen.
Participant Enrollment Criteria
-
18-64 years of age
-
Confirmed positive COVID-19 infection within the last 5 days
-
BMI under 30
-
Not a current cigarette smoker (vaping or THC ok; past history of smoking OK)
-
No history of cardiovascular or lung disease
-
No diabetes
-
Not currently on dialysis
-
Additional criteria may apply
Participants Will Receive
-
Receive access to study related medical equipment
-
Receive compensation of $1,000+
Location and Time
​
-
All appointments are located at Eastside Research Associates in Redmond, WA
-
Study duration approximately 1 month
bottom of page